B
BFRG
vs
S&P 500
S&P 500
Over the past 12 months, BFRG has underperformed S&P 500, delivering a return of -76% compared to the S&P 500's +15% growth.
Stocks Performance
BFRG vs S&P 500
Performance Gap
BFRG vs S&P 500
Performance By Year
BFRG vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bullfrog AI Holdings, Inc.
Glance View
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company is headquartered in Gaithersburg, Maryland and currently employs 2 full-time employees. The company went IPO on 2023-02-14. The firm is focused on advanced artificial intelligence/machine learning (AI/ML)-driven analysis of complex data sets in medicine and healthcare. Its platform technology, bfLEAP, is an analytical AI/ML platform, which is a potentially disruptive tool for analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational R&D and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize it against other disparate data sources from patients. The Company’s therapeutic pipeline includes siRNA and Mebendazole. Its siRNA targeting Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), treatment of obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.
